Literature DB >> 20638468

Regulation of the Vibrio vulnificus vvpE expression by cyclic AMP-receptor protein and quorum-sensing regulator SmcR.

Choon-Mee Kim1, Sung-Heui Shin.   

Abstract

In Vibrio vulnificus, cAMP-receptor protein (CRP) and the quorum-sensing regulator SmcR are simultaneously and cooperatively required for the metalloprotease vvpE gene expression, rather than sequentially in a regulatory cascade. However, this study shows a new temporal and functional sequence between the two factors in regulating vvpE expression. A crp mutation inhibited vvpE expression with growth impairment from early stage. In contrast, a smcR mutation inhibited vvpE expression only at the late stage with no effect on growth. A crp-smcR double mutation severely inhibited vvpE expression with growth impairment from early stage. The inhibited vvpE expression was restored only at the early stage by a crp single complementation, but not at all by a smcR complementation. These results indicate that CRP functions as an essential activator, whereas SmcR functions in the presence of CRP for full vvpE expression.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638468     DOI: 10.1016/j.micpath.2010.07.003

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  3 in total

1.  Involvement of the global Crp regulator in cyclic AMP-dependent utilization of aromatic amino acids by Pseudomonas putida.

Authors:  M Carmen Herrera; Abdelali Daddaoua; Ana Fernández-Escamilla; Juan-Luis Ramos
Journal:  J Bacteriol       Date:  2011-11-11       Impact factor: 3.490

2.  Cyclic AMP and cyclic AMP-receptor protein modulate the autoinducer-2-mediated quorum sensing system in Vibrio vulnificus.

Authors:  Sun-Pyo Kim; Choon-Mee Kim; Sung-Heui Shin
Journal:  Curr Microbiol       Date:  2012-09-09       Impact factor: 2.188

3.  Effects of temperature, growth phase and luxO-disruption on regulation systems of toxin production in Vibrio vulnificus strain L-180, a human clinical isolate.

Authors:  Abdelaziz Elgaml; Kazutaka Higaki; Shin-ichi Miyoshi
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.